Advocating for a world where intellectual
property law serves the public interest.

The Right to Read

[Linda Daniels] The Copyright Amendment Bill gives those with disabilities greater access to copyrighted material while supporting education and creators. But it is yet to be signed into law and not everyone is behind it.

Patent Inventorship and Ownership Issues on Inventions Developed by Humans Using Artificial Intelligence

[Pratap Devarapalli] Abstract: Artificial intelligence (AI) is immensely capable of questioning this human ‘self-awareness’ by replicating the human potential to think, sense and also to make decisions in any knowledge field. Advanced research in AI has identified increasingly diverse applications of AI all over the globe. One of the crucial aspects of these AI programs is; even though the instructions

Article 17 Stakeholder Dialogue: We’ll Continue to Advocate for Safeguarding User Rights

[Paul Keller] Article 17(10) of the Copyright in the Digital Single Market directive requires the Commission to “organise stakeholder dialogues to discuss best practices for cooperation between online content-sharing service providers and rightholders”. Based on the outcome of these dialogues with “content-sharing service providers, rightholders, users’ organisations and other relevant stakeholders” the Commission is expected to “issue guidance on the

How to license Article 17? Exploring the Implementation Options for the New EU Rules on Content-Sharing Platforms

[Martin Husovec and João Quintais] Abstract: How can the EU Member States license Article 17 of the new Directive on copyright and related rights in the Digital Single Market? This is the central question that this paper addresses. To answer it, we first analyse the nature of the right included in Article 17. We argue that the nature of the

Pharmaceutical ‘Pay-for-Delay’ Reexamined: A Dwindling Practice or a Persistent Problem?

[Laura Karas, Gerard F. Anderson and Robin Feldman] Abstract: The Supreme Court ruled in FTC v. Actavis that a delay in generic entry may be anticompetitive when part of a patent settlement that includes a large and otherwise unjustified value transfer to the generic company, termed a reverse payment patent settlement, or “pay-for-delay.” Following Actavis, drug companies have limited the

SPARC Releases Connect OER Annual Report for 2018-2019

[Scholarly Publishing and Academic Resources Coalition] SPARC is pleased to release our 2018-2019 Connect OER Annual Report, which offers insights about OER activities across North America. This year’s report examines the current state of OER activities featuring data from 132 institutions in the U.S. and Canada. Our intent is that these insights will help inform SPARC members, open education advocates,